Initial Physician Experience with [(18)F]Flutemetamol Amyloid PET Imaging Following Availability for Routine Clinical Use in Japan

BACKGROUND: Brain amyloid is a neuropathological hallmark of Alzheimer’s disease (AD). By visualizing brain amyloid, positron emission tomography (PET) may influence the diagnostic assessment and management of patients with cognitive impairment. OBJECTIVE: As part of a Japanese post-approval study t...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:J Alzheimers Dis Rep
Autors principals: Hattori, Naoya, Sherwin, Paul, Farrar, Gill
Format: Artigo
Idioma:Inglês
Publicat: IOS Press 2020
Matèries:
Research Report
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC7369136/
https://ncbi.nlm.nih.gov/pubmed/32715277
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3233/ADR-190150
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars